David Hallett's most recent trade in Recursion Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 26,657 Class A Common Stock done at an average price of $3.0 . Disclosure was reported to the exchange on May 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Recursion Pharma Inc (Class A) | David Hallett | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.04 per share. | 15 May 2026 | 26,657 | 1,070,494 | - | 3.0 | 81,037 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | David Hallett | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.49 per share. | 17 Feb 2026 | 11,908 | 1,097,151 | - | 3.5 | 41,559 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | David Hallett | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2026 | 502,064 | 1,096,205 | - | 0 | Class A Common Stock | |
| Recursion Pharma Inc (Class A) | David Hallett | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2026 | 24,254 | 1,120,459 | - | 0 | Class A Common Stock | |
| Recursion Pharma Inc (Class A) | David Hallett | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.98 per share. | 06 Feb 2026 | 11,400 | 1,109,059 | - | 4.0 | 45,372 | Class A Common Stock |